BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1241122)

  • 1. The CEA test in urologic cancer: an evaluation and a review.
    Guinan P; Dubin A; Bush I; Alsheik H; Ablin RJ
    Oncology; 1975; 32(3-4):158-68. PubMed ID: 1241122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carcinoembryonic antigen test in urologic cancer.
    Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
    Sanford EJ; Drago JR; Rohner TJ; Kessler GF; Sheehan L; Lipton A
    J Urol; 1975 Feb; 113(2):218-21. PubMed ID: 1113419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of urinary tract. Clinical significance of urinary phosphokinase activity in diagnosis.
    Block NL; Jaksy J; Tessler AN
    Urology; 1974 Aug; 4(2):174-81. PubMed ID: 4850881
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
    Coombers GB; Hall RR; Laurence JR; Neville AM
    Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholesterol and urinary tract diseases].
    Frick J; Spiteller G
    Z Urol Nephrol; 1968 Dec; 61(12):833-8. PubMed ID: 4183283
    [No Abstract]   [Full Text] [Related]  

  • 8. Exfoliative cytology in urine.
    Tsai SY; Laughlin VC; Goodsitt E; Basa A
    J Urol; 1968 Mar; 99(3):342-4. PubMed ID: 4869567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CEA determination in urogenital tract neoplasms].
    Hering H; Weidner W; Hering F
    Med Lab (Stuttg); 1976 Sep; 29(9):193-8. PubMed ID: 979885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary excretion of cholesterol in various diseases. (Especially in cancer of the urogenital system)].
    Spiteller-Friedmann M; Spiteller G; Spiteller H; Frick J
    Osterr Z Erforsch Bekampf Krebskr; 1971; 26(1):25-35. PubMed ID: 5171242
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease.
    Fleisher M; Grabstald H; Whitmore WF; Pinsky CM; Oettgen HF; Schwartz MK
    J Urol; 1977 May; 117(5):635-7. PubMed ID: 558345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Special problems of early detection of malignant tumors of the genito-urinary system (author's transl)].
    Mebel M; Vogler H
    Arch Geschwulstforsch; 1981; 51(8):679-84. PubMed ID: 6176207
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the clinical significance of nonesterified and total cholesterol in urine.
    Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
    Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.
    Fukutani K; Libby JM; Panko WB; Scardino PT
    J Urol; 1983 Jan; 129(1):74-7. PubMed ID: 6827688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
    Alsabti EA; Kamel A
    Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.